Alto Neuroscience, Inc.
ANRO
$2.28
$0.010.44%
NYSE
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.43% | -4.70% | -19.48% | -19.61% | -22.71% |
| Total Depreciation and Amortization | 39.34% | 7.96% | 16.49% | -13.39% | 77.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -11.07% | -23.06% | 7.75% | 251.70% | 53.86% |
| Change in Net Operating Assets | -96.45% | 94.83% | 660.78% | 77.94% | -238.61% |
| Cash from Operations | -11.04% | -0.27% | -6.47% | 4.69% | -48.41% |
| Capital Expenditure | 49.65% | -195.59% | -51.79% | 36.36% | -718.60% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 49.65% | -195.59% | -51.79% | 36.36% | -718.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -26.87% | 9.84% | -99.96% | 474,344.83% | -73.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | 523.73% | 90.26% | -59.73% | -3,061.67% |
| Cash from Financing | -96.28% | 662.82% | -100.17% | 211.97% | 87,924.49% |
| Foreign Exchange rate Adjustments | 185.71% | -40.00% | 0.00% | -225.00% | -77.78% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.96% | 6.94% | -109.95% | 294.58% | 503.82% |